Ford Takes $19.5 Billion Charge as EV Strategy Shifts Toward Hybrids 
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation 
Robinhood Expands Sports Event Contracts With Player Performance Wagers 
Korea Zinc to Build $7.4 Billion Critical Minerals Refinery in Tennessee With U.S. Government Backing 
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit 
FAA Unveils Flight Plan 2026 to Strengthen Aviation Safety and Workforce Development 
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness 
Trump Sues BBC for Defamation Over Edited Capitol Riot Speech Clip 
Fortescue Expands Copper Portfolio With Full Takeover of Alta Copper 
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates 
United Airlines Tokyo-Bound Flight Returns to Dulles After Engine Failure 
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 
EU Signals Major Shift on 2035 Combustion Engine Ban Amid Auto Industry Pressure 
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate 
noyb Files GDPR Complaints Against TikTok, Grindr, and AppsFlyer Over Alleged Illegal Data Tracking. 
Strategy Retains Nasdaq 100 Spot Amid Growing Scrutiny of Bitcoin Treasury Model 
MINNEAPOLIS, Sept. 12, 2016 -- Vital Images, Inc. (Vital), a Minneapolis-based advanced medical imaging and informatics company, is pleased to announce the support of Nuance PowerScribe® 360 Reporting and PenRad™ PenLung™ Lung Screening Management system in its comprehensive Lung Screening solution. The Vitrea® CT Lung Analysis application helps clinicians standardize the diagnosis of lung nodules, while the solution’s workflow system facilitates management of lung screening treatment plans.
Nuance’s PowerScribe 360 is the market-leading speech recognition technology for radiology, providing accurate, flexible and rapid reporting that is consistent and actionable. The high-quality reports generated by PowerScribe 360 can help healthcare organizations improve both patient care and physician satisfaction, and optimize billing and reimbursement.
PenLung by PenRad is a unified software solution that helps radiology departments and imaging facilities manage patients participating in low-dose computed tomography (LDCT) lung screening programs. It collects smoking and environmental risk history through automated web and tablet calculators to manage patient eligibility and export of the lung registry for reimbursement.
“We are excited to announce the support of PowerScribe 360 and PenLung as part of our comprehensive Lung Screening solution offering to healthcare organizations,” says Jim Litterer, President and CEO of Vital. “The integration of these powerful tools with CT Lung Screening can help providers continue to improve patient outcomes by streamlining both workflow and treatment plan management.”
About Vital Images, Inc.
Vital Images, Inc., a Toshiba Medical Systems Group company, is a leading provider of diagnostic imaging and enterprise informatics solutions to help healthcare organizations deliver exceptional care while optimizing resources across multi-facility organizations. The company's solutions are scalable to meet the unique needs of hospitals and imaging centers and are accessible throughout the enterprise anytime, anywhere. For more information, visit www.vitalimages.com or join the conversation on Twitter, LinkedIn and YouTube.
Vitrea is a trademark of Vital Images, Inc.
Marks not owned by Vital Images, Inc. are the property of their respective holders.
AT VITAL IMAGES: Aaron Wangen (952) 487-9632 [email protected] www.vitalimages.com
